Back to search

National and Kapodistrian University of Athens

Αναζήτηση προβλεπτικών ιστικών δεικτών στους όγκους εκ γεννητικών κυττάρων των όρχεων

Abstract

dc:description

Testicular Germ Cell Tumors (TGCTs) are the most frequent solid malignancies in young adult men. Regardless of differences in their cell of origin, all TGCTs are considered highly curable malignancies. However, approximately 3-5% of all TGCTs and 10-15% of initially advanced TGCTs do not respond to platinum-based chemotherapies, often resulting in death. The purpose of our paper is to investigate whether immunohistochemical expression of MLH1 and REV-7 can be used as predictive tissue markers for TGCTs. The main demographic and clinicopathological characteristics of 64 male patients with TGCTs were retrospectively obtained from two large Oncology Clinics in Greece. Patients had undergone orchiectomy from 2007 to 2022, in five renowned Centers in Greece. 31 seminomas and 33 non-seminomas were included. 48 patients had chemosensitive disease, while 16 had chemoresistant disease. 53 specimens showed preserved MLH1 expression in nuclei of cancer cells, while 11 specimens had lost MLH1 expression. Expression of MLH1 was only significantly associated with lower patients’ age and not with chemoresistance. 8 out of 16 patients (50.0%) with chemoresistant disease and 8 out of 48 patients (16.7%) with chemosensitive disease were REV-7 positive. This difference was statistically significant. Moreover, REV-7 positivity was significantly associated with various clinicopathological parameters and patients’ prognosis and survival. More precisely, positive REV-7 expression was associated with significantly lower survival and a 14.76 times greater hazard. Positive immunohistochemical expression of REV-7 has been reported in several different types of cancer, including testicular cancer, ovarian cancer, esophagus squamous cell carcinoma, prostate cancer, colorectal cancer, diffuse large B-cell lymphoma, breast cancer, lung cancer and skin cancer. High REV-7 expression has been associated with faster disease progression, resistance to available management options and worse prognosis in the majority of these tumors. Promising results, arising from REV-7 inactivation experiments, render REV-7 targeting a potential therapeutic strategy for future cancer management, especially in the cases of chemoresistant or radioresistant disease. Our findings imply that immunohistochemical staining for REV-7 could potentially be used as a predictive tissue marker for TGCT tumors. Additional well-designed studies on larger patient populations are needed so as to draw safer conclusions.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Spinos, Theodoros
  • Σπίνος, Θεόδωρος

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/56902

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Spinos, Theodoros; Σπίνος, Θεόδωρος. Αναζήτηση προβλεπτικών ιστικών δεικτών στους όγκους εκ γεννητικών κυττάρων των όρχεων. National and Kapodistrian University of Athens, 2024. http://hdl.handle.net/10442/hedi/56902